ANGPTL4通过内皮 - 介质细胞过渡促进胆道新血管化和亚皮纤维化
Jia Chen1,2, Ying Yang2,3, Shu Su1,2
1Suzhou Medical College of Soochow University, Suzhou, 215123, China.
International ophthalmology
|November 25, 2024
概括
血管类4 (ANGPTL4) 通过诱导内皮细胞-介质细胞过渡 (EndMT) 来促进胆管新血管化和纤维化. 抑制ANGPTL4可能为与年龄相关的黄斑变性提供一种新的治疗策略.
科学领域:
- 眼科医生 眼科 眼科
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 与年龄相关的黄斑变性 (AMD) 是导致视力丧失的主要原因.
- 状新血管化 (CNV) 和亚皮纤维化是新血管AMD (nAMD) 的关键病理特征.
- CNV和纤维化背后的分子机制需要进一步阐明.
研究的目的:
- 为了研究ANGPTL4在CNV和子纤维化病变发生过程中的作用.
- 探索ANGPTL4作为nAMD治疗点的潜力.
主要方法:
- 对nAMD中差异表达基因的GEO数据库的生物信息分析.
- 建立和验证激光诱导的CNV小鼠模型.
- 在体外研究中使用TGF-β2诱导的人类静脉内皮细胞 (HUVEC) 来建模EndMT.
- 在体外和体内使用小干扰RNA (siRNA) 降低ANGPTL4.
- 评估CNV和纤维化使用 fundus光素血管学 (FFA),光学连贯性断层扫描血管学 (OCTA) 和免疫光染色.
主要成果:
- 在CNV小鼠模型和TGF-β2诱导的EndMT中,ANGPTL4表达显著上调.
- ANGPTL4的淘汰抑制了EndMT,细胞迁移和在体外的入侵.
- 通过抑制EndMT,ANGPTL4 Knockdown减少了体内中枢神经瘤的形成和子皮膜纤维化.
结论:
- ANGPTL4促进中枢神经瘤和亚纤维化,可能是通过诱导EndMT.
- ANGPTL4代表了对nAMD的一个潜在的新疗法标.
更多相关视频
07:05TGF-β-mediated Endothelial to Mesenchymal Transition EndMT and the Functional Assessment of EndMT Effectors using CRISPR/Cas9 Gene Editing
Published on: February 26, 2021
5.1K
07:49Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
Published on: August 3, 2018
11.3K
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Mechanism of Angiogenesis
5.3K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.3K
